DNAnexus
Latest round
- Series I
Last raised
- Mar 2022
Total raised
- $458M
Investors
- 16
About DNAnexus
DNAnexus, Inc.Founded in 2009 and headquartered in Mountain View, California, DNAnexus focuses on precision health data solutions.000 mn.054 mn.DNAnexus specializes in providing a comprehensive cloud-based platform tailored for precision health data management and analysis. Their core offerings allow biomedical organizations to efficiently manage, analyze, and collaborate on multimodal data sets, which play a crucial role in advancing scientific research and patient care. Key functionalities include streamlined data ingestion, organization, integration of omics datasets, and access to a robust library of bioinformatics tools, enabling users to deploy pipelines and AI/ML algorithms swiftly. The platform is designed to break down data silos by providing a unified source of truth, thereby facilitating seamless collaboration among internal teams and external partners.DNAnexus generates revenue through subscriptions and strategic partnerships, primarily focusing on B2B transactions. Their business model allows clients, including large pharmaceutical firms and diagnostic companies, to access their platform's capabilities via structured subscription plans that cater to varying levels of service and functionality. The platform's flagship offerings, such as NGS data analysis and translational informatics, drive engagement from clientele, enabling organizations to leverage their data for insightful analysis and decision-making. Revenue is derived from subscription fees that provide clients access to the tools and services necessary for effective genomic computing and data management, ensuring compliance with industry regulations and standards.000 mn, to accelerate its genomics platform, enhance its global growth, and incorporate new AI and machine learning technologies. The company is focused on expanding its offerings and entering new markets, aiming to reach broader segments within Europe and Asia by 2024. This strategy aligns with their commitment to improve precision health outcomes through advanced technological integration.
Who invested in DNAnexus
16 investors across 7 rounds
See all investors in DNAnexus
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series I
Mar 3, 2022
Amount
$200M
Investors
Series H
Jun 5, 2020
Amount
$100M
Investors
Series F
Jun 24, 2019
Amount
$68M
Investors
Series E
Jan 2, 2018
Amount
$58M
Investors
Series C
Dec 20, 2013
Amount
$15M
Investors
Series B
Oct 12, 2011
Amount
$15M
Investors
Series A
May 13, 2009
Amount
$1.6M
Investors
Questions about DNAnexus
Who invested in DNAnexus?
DNAnexus has 16 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DNAnexus raised?
DNAnexus has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did DNAnexus last raise money?
DNAnexus's most recent round on record is a Series I, in Mar 2022.
What does DNAnexus do?
DNAnexus is a software company.
Where is DNAnexus headquartered?
DNAnexus is headquartered in Mountain View, US.
Which VCs invest in companies like DNAnexus?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at DNAnexus's stage. Their profiles are linked below.
VCs backing software startups at Series I
Raising like DNAnexus? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.